查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球肺炎檢測市場規模研究和預測：按產品類型、類型、最終用戶和地區分析，2022-2029
市場調查報告書
商品編碼
1215433

全球肺炎檢測市場規模研究和預測：按產品類型、類型、最終用戶和地區分析，2022-2029

Global Pneumonia Testing Market Size study & Forecast, by Product Type by Type, by End-user and Regional Analysis, 2022-2029
出版日期: | 出版商: Bizwit Research & Consulting LLP | 英文 | 商品交期: 2-3個工作天內

價格

稱為肺炎的肺部感染是由細菌、真菌或病毒引起的。

肺泡是肺部的氣囊，因液體和膿液而發炎和腫脹。 咳嗽、發燒、發冷和呼吸困難是肺炎最常見的一些症狀。 肺炎檢測□□包括體格檢查、病史、胸部 X 光檢查、血培養、脈搏血氧儀、痰培養、支氣管鏡檢查和液體取樣。 對肺炎的興趣增加導致這種疾病的流行和早期診斷增加。 即時檢驗 (POC) 檢測的普及、核酸檢測技術的進步以及老年人口的增加也是增長的因素。

在預測期內，肺炎患病率的上升將為肺炎檢測市場創造有利可圖的需求。 例如，根據 2019 年聯合國兒童基金會（聯合國國際兒童基金會）的一篇文章，全球每 10 萬人中有超過 1,400 例肺炎病例。 此外，南亞和西非和中非的發病率最高，分別為每 10 萬兒童 2,500 例和 1,620 例。 因此，上述原因已成為市場的重要增長動力。 此外，肺炎檢測技術的進步是有望推動這一增長的關鍵方面之一。 基於先進的多重 PCR (mPCR) 的肺炎診斷技術提供了更高的檢測效率，最大限度地減少了成本和時間。 例如，2018年，在美國，Curetis推出了Unyvero System和LRT Cartridge。 該方法利用強大的多重 PCR 技術輕鬆確定從樣品到反應的各種細菌、抗生素耐藥性指標或毒素。 預計在預測期內，增加護理點 (POC) 測試的利用率也將為市場創造有利可圖的機會。 然而，胸部 X 光作為檢測肺炎的重要工具的廣泛使用阻礙了整個 2022-2029 年預測期內的市場增長。

全球肺炎檢測市場研究中考慮的主要區域是亞太地區、北美、歐洲、拉丁美洲和世界其他地區。 由於肺炎患者人數的增加、有利的報銷政策以及護理點技術的日益普及，北美已成為世界市場份額的主導地區。 另一方面，由於老年人口增加和肺炎患者數量增加等因素，預計亞太地區在預測期內將呈現高增長率，為亞洲肺炎檢測市場創造良好的增長前景-太平洋地區，這是可能的。

這項研究的目的是定義近年來各個細分市場和國家的市場規模，並預測未來幾年的價值。 該報告旨在捕捉被調查國家工業的定性和定量方面的情況。

它還提供了關鍵方面的詳細信息，例如決定市場未來增長的驅動因素和挑戰。 此外，它還包含供利益相關者投資的微觀市場潛在機會，以及對主要參與者的競爭格局和產品供應的深入分析。

內容

第 1 章執行摘要

  • 市場概況
  • 2019-2029 年全球市場和細分市場的估計和預測
    • 肺炎檢測市場：按地區劃分，2019-2029 年
    • 肺炎檢測市場：按產品類型分類，2019-2029 年
    • 肺炎檢測市場，按類型，2019-2029
    • 肺炎檢測市場：按最終用戶分類，2019-2029 年
  • 主要趨勢
  • 調查方法介紹
  • 調查先決條件

第 2 章全球肺炎檢測市場定義和範圍

  • 調查的目的
  • 市場定義和範圍
    • 調查範圍
    • 工業發展
  • 調查年份
  • 貨幣兌換率

第三章全球肺炎檢測市場動態

  • 肺炎檢測市場影響分析 (2019-2029)
    • 市場驅動力
      • 肺炎患病率上升
      • 肺炎檢測的技術進步
    • 市場挑戰
      • 使用胸部 X 光檢查作為檢測肺炎的重要工具
    • 市場機會
      • 擴大床旁 (POC) 檢測的使用範圍

第 4 章肺炎檢測全球市場行業分析

  • 波特 5 力模型
    • 供應商的議價能力
    • 買家的議價能力
    • 新進入者的威脅
    • 替代品的威脅
    • 競爭公司之間的敵對關係
  • 波特 5 力模型的未來方法 (2019-2029)
  • 害蟲分析
    • 政治
    • 經濟的
    • 社交
    • 技術
  • 頂級投資機會
  • 關鍵成功策略
  • 行業專家的展望
  • 分析師的結論和建議

第 5 章風險評估：COVID-19 的影響

  • 評估 COVID-19 對行業的總體影響
  • COVID-19 之前和 COVID-19 之後的市場情景

第 6 章按產品類型分列的全球肺炎檢測市場

  • 市場概況
  • 全球肺炎檢測市場：按產品類型、性能潛力分析
  • 2019-2029 年按產品類型估計和預測的全球肺炎檢測市場
  • 全球肺炎檢測市場，細分分析
    • 樂器
    • 試劑和耗材

第 7 章：全球肺炎檢測市場，按類型

  • 市場概況
  • 全球肺炎檢測市場：按類型、性能潛力分析
  • 2019-2029 年全球肺炎檢測市場、按類型估計和預測
  • 肺炎檢測市場，細分分析
    • 鏈球菌基地
    • 軍團菌基地
    • 衣原體
    • 基於病毒性肺炎
    • 肺炎支原體
    • 其他

第 8 章全球肺炎檢測市場：按最終用戶分類

  • 市場概況
  • 全球肺炎檢測市場：最終用戶表現 - 潛力分析
  • 2019-2029 年全球肺炎檢測市場、最終用戶估計和預測
  • 肺炎檢測市場，細分分析
    • 醫院和診所
    • 診斷中心
    • 其他

第 9 章：全球肺炎檢測市場：區域分析

  • 肺炎檢測市場，按地區劃分的市場概況
  • 北美
    • 美國
      • 按產品類型估算和預測，2019 年至 2029 年
      • 按類型估算和預測，2019-2029 年
      • 2019-2029 年最終用戶的估計和預測
    • 加拿大
  • 歐洲肺炎檢測市場概況
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 意大利
    • 其他歐洲地區
  • 亞太地區肺炎檢測市場概況
    • 中國
    • 印度
    • 日本
    • 澳大利亞
    • 韓國
    • 其他亞太地區
  • 拉丁美洲肺炎檢測市場概況
    • 巴西
    • 墨西哥
    • 其他拉丁美洲地區
  • 世界其他地區

第 10 章衝突信息

  • 頂級市場策略
  • 公司簡介
    • Quidel 公司（美國）
      • 主要信息
      • 概覽
      • 財務信息（取決於數據可用性）
      • 產品概述
      • 近期趨勢
    • Abbott（U.S.）
    • bioMerieux SA（France）
    • Thermo Fisher Scientific Inc.（U.S.）
    • INTEC（China）
    • OpGen（U.S.）
    • Meridian Bioscience, Inc.（U.S.）
    • BD（Becton, Dickinson, and Company）（U.S.）
    • Luminex Corporation（DiaSorin S.p.A.）（U.S.）
    • Roche Holding AG（Switzerland）

第 11 章研究過程

  • 研究過程
    • 數據挖掘
    • 分析
    • 市場評估
    • 驗證
    • 出版
  • 調查屬性
  • 調查先決條件

Global Pneumonia Testing Market is valued approximately USD XXX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XXX% over the forecast period 2022-2029. A lung infection known as pneumonia is caused by the bacteria, fungus, or viruses. Alveoli, the air sacs in the lungs, become inflamed and swell with fluid or pus as a result of the infection. Cough, fever, chills, and breathing difficulties are a few of the pneumonia symptoms that are frequently seen. Physical examination, evaluation of medical history, chest X-ray, blood culture, pulse oximetry, sputum culture, bronchoscopy, and fluid sample make the pneumonia testing process for this disease. The rise in concerns about pneumonia has led to an increase in the prevalence of the disease and early diagnosis. Also, another factor driving the growth is Increased use of point of care (POC) testing and technological advancements, such as nucleic acid detection worldwide, as well as a growth in the number of geriatric populations.

The rising prevalence of pneumonia will create the lucrative demand for the pneumonia testing market during forecast period. For instance, according to a 2019 UNICEF (United Nations International Children's Emergency Fund) article, there are more than 1,400 cases of pneumonia per 100,000 people worldwide. Additionally, with 2,500 cases and 1,620 cases per 100,000 children, respectively, South Asia and West and Central Africa have the highest incidence of it. Therefore, the above reasons are significant growth drivers for the market. Additionally, technology advancements in pneumonia testing are one of the key aspects that are expected to fuel this growth. Higher detection efficiency is provided by the advanced multiplex PCR (mPCR) based technology for diagnosing pneumonia, which minimizes cost and time. For instance, in 2018, in the US, Curetis launched the Unyvero System and LRT Cartridge. The method utilizes powerful multiplex PCR technology to easily determine a wide range of bacteria, indicators of antibiotic resistance, or toxins from sample to response. Also, rising use of point of care (POC) testing would create the lucrative opportunity for the market during forecast period. However, the widespread utilization of chest X-rays as an essential tool for pneumonia detection stifles market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Pneumonia Testing Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is the dominating region across the world in terms of market share, owing to the rising number of pneumonia cases, favorable reimbursement policy and growing adoption of point-of-care technologies. Whereas, Asia Pacific is also anticipated to exhibit highest growth rate over the forecast period, owing to factors such as increasing geriatric population and growing cases of pneumonia would create lucrative growth prospects for the Pneumonia Testing market across Asia Pacific region.

Major market players included in this report are:

Quidel Corporation (U.S.)

Abbott (U.S.)

bioMerieux SA (France)

Thermo Fisher Scientific Inc. (U.S.)

INTEC (China)

OpGen (U.S.)

Meridian Bioscience, Inc. (U.S.)

BD (Becton, Dickinson, and Company) (U.S.)

Luminex Corporation (DiaSorin S.p.A.) (U.S.)

Roche Holding AG (Switzerland)

Recent Developments in the Market:

  • September 2021: CerTest Biotec developed and tested its CE-IVD multiplex assay VIASURE M. pneumoniae, L. pneumophila and C. pneumoniae real-time PCR kit for detection of principal pathogens implicated in atypical pneumoniae.
  • February 2021: Mesa Biotech, Inc. was fully acquired by Thermo Fisher Scientific Inc. The company would be able to grow its molecular diagnostics sector with the acquisition.

Global Pneumonia Testing Market Report Scope:

Historical Data: 2019-2020-2021

Base Year for Estimation: 2021

Forecast period: 2022-2029

Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends

Segments Covered: Product Type, Type, End-user, Region

Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World

Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product Type:

Instruments

Reagents & Consumables

By Type:

Streptococcus-based

Legionella-based

Chlamydophila-based

Viral Pneumonia-based

Mycoplasma Pneumonia-based

Others

By End-user:

Hospitals & Clinics

Diagnostic Centers

Others

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

RoLA

Rest of the World

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
    • 1.2.1. Pneumonia Testing Market, by Region, 2019-2029 (USD Billion)
    • 1.2.2. Pneumonia Testing Market, by Product Type, 2019-2029 (USD Billion)
    • 1.2.3. Pneumonia Testing Market, by Type, 2019-2029 (USD Billion)
    • 1.2.4. Pneumonia Testing Market, by End-user, 2019-2029 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Pneumonia Testing Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Pneumonia Testing Market Dynamics

  • 3.1. Pneumonia Testing Market Impact Analysis (2019-2029)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Rising Prevalence of Pneumonia
      • 3.1.1.2. Technology advancements in pneumonia testing
    • 3.1.2. Market Challenges
      • 3.1.2.1. Utilization of chest x-rays as an essential tool for pneumonia detection
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Rising use of point of care (poc) testing

Chapter 4. Global Pneumonia Testing Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
  • 4.4. Top investment opportunity
  • 4.5. Top winning strategies
  • 4.6. Industry Experts Prospective
  • 4.7. Analyst Recommendation & Conclusion

Chapter 5. Risk Assessment: COVID-19 Impact

  • 5.1. Assessment of the overall impact of COVID-19 on the industry
  • 5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Pneumonia Testing Market, by Product Type

  • 6.1. Market Snapshot
  • 6.2. Global Pneumonia Testing Market by Product Type, Performance - Potential Analysis
  • 6.3. Global Pneumonia Testing Market Estimates & Forecasts by Product Type 2019-2029 (USD Billion)
  • 6.4. Pneumonia Testing Market, Sub Segment Analysis
    • 6.4.1. Instruments
    • 6.4.2. Reagents & Consumables

Chapter 7. Global Pneumonia Testing Market, by Type

  • 7.1. Market Snapshot
  • 7.2. Global Pneumonia Testing Market by Type, Performance - Potential Analysis
  • 7.3. Global Pneumonia Testing Market Estimates & Forecasts by Type 2019-2029 (USD Billion)
  • 7.4. Pneumonia Testing Market, Sub Segment Analysis
    • 7.4.1. Streptococcus-based
    • 7.4.2. Legionella-based
    • 7.4.3. Chlamydophila-based
    • 7.4.4. Viral Pneumonia-based
    • 7.4.5. Mycoplasma Pneumonia-based
    • 7.4.6. Others

Chapter 8. Global Pneumonia Testing Market, by End-user

  • 8.1. Market Snapshot
  • 8.2. Global Pneumonia Testing Market by End-user, Performance - Potential Analysis
  • 8.3. Global Pneumonia Testing Market Estimates & Forecasts by End-user 2019-2029 (USD Billion)
  • 8.4. Pneumonia Testing Market, Sub Segment Analysis
    • 8.4.1. Hospitals & Clinics
    • 8.4.2. Diagnostic Centers
    • 8.4.3. Others

Chapter 9. Global Pneumonia Testing Market, Regional Analysis

  • 9.1. Pneumonia Testing Market, Regional Market Snapshot
  • 9.2. North America Pneumonia Testing Market
    • 9.2.1. U.S. Pneumonia Testing Market
      • 9.2.1.1. Product Type breakdown estimates & forecasts, 2019-2029
      • 9.2.1.2. Type breakdown estimates & forecasts, 2019-2029
      • 9.2.1.3. End-user breakdown estimates & forecasts, 2019-2029
    • 9.2.2. Canada Pneumonia Testing Market
  • 9.3. Europe Pneumonia Testing Market Snapshot
    • 9.3.1. U.K. Pneumonia Testing Market
    • 9.3.2. Germany Pneumonia Testing Market
    • 9.3.3. France Pneumonia Testing Market
    • 9.3.4. Spain Pneumonia Testing Market
    • 9.3.5. Italy Pneumonia Testing Market
    • 9.3.6. Rest of Europe Pneumonia Testing Market
  • 9.4. Asia-Pacific Pneumonia Testing Market Snapshot
    • 9.4.1. China Pneumonia Testing Market
    • 9.4.2. India Pneumonia Testing Market
    • 9.4.3. Japan Pneumonia Testing Market
    • 9.4.4. Australia Pneumonia Testing Market
    • 9.4.5. South Korea Pneumonia Testing Market
    • 9.4.6. Rest of Asia Pacific Pneumonia Testing Market
  • 9.5. Latin America Pneumonia Testing Market Snapshot
    • 9.5.1. Brazil Pneumonia Testing Market
    • 9.5.2. Mexico Pneumonia Testing Market
    • 9.5.3. Rest of Latin America Pneumonia Testing Market
  • 9.6. Rest of The World Pneumonia Testing Market

Chapter 10. Competitive Intelligence

  • 10.1. Top Market Strategies
  • 10.2. Company Profiles
    • 10.2.1. Quidel Corporation (U.S.)
      • 10.2.1.1. Key Information
      • 10.2.1.2. Overview
      • 10.2.1.3. Financial (Subject to Data Availability)
      • 10.2.1.4. Product Summary
      • 10.2.1.5. Recent Developments
    • 10.2.2. Abbott (U.S.)
    • 10.2.3. bioMerieux SA (France)
    • 10.2.4. Thermo Fisher Scientific Inc. (U.S.)
    • 10.2.5. INTEC (China)
    • 10.2.6. OpGen (U.S.)
    • 10.2.7. Meridian Bioscience, Inc. (U.S.)
    • 10.2.8. BD (Becton, Dickinson, and Company) (U.S.)
    • 10.2.9. Luminex Corporation (DiaSorin S.p.A.) (U.S.)
    • 10.2.10. Roche Holding AG (Switzerland)

Chapter 11. Research Process

  • 11.1. Research Process
    • 11.1.1. Data Mining
    • 11.1.2. Analysis
    • 11.1.3. Market Estimation
    • 11.1.4. Validation
    • 11.1.5. Publishing
  • 11.2. Research Attributes
  • 11.3. Research Assumption

LIST OF TABLES

  • TABLE 1. Global Pneumonia Testing Market, report scope
  • TABLE 2. Global Pneumonia Testing Market estimates & forecasts by Region 2019-2029 (USD Billion)
  • TABLE 3. Global Pneumonia Testing Market estimates & forecasts by Product Type 2019-2029 (USD Billion)
  • TABLE 4. Global Pneumonia Testing Market estimates & forecasts by Type 2019-2029 (USD Billion)
  • TABLE 5. Global Pneumonia Testing Market estimates & forecasts by End-user 2019-2029 (USD Billion)
  • TABLE 6. Global Pneumonia Testing Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 7. Global Pneumonia Testing Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 8. Global Pneumonia Testing Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 9. Global Pneumonia Testing Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 10. Global Pneumonia Testing Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 11. Global Pneumonia Testing Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 12. Global Pneumonia Testing Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 13. Global Pneumonia Testing Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 14. Global Pneumonia Testing Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 15. Global Pneumonia Testing Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 16. U.S. Pneumonia Testing Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 17. U.S. Pneumonia Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 18. U.S. Pneumonia Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 19. Canada Pneumonia Testing Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 20. Canada Pneumonia Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 21. Canada Pneumonia Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 22. UK Pneumonia Testing Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 23. UK Pneumonia Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 24. UK Pneumonia Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 25. Germany Pneumonia Testing Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 26. Germany Pneumonia Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 27. Germany Pneumonia Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 28. France Pneumonia Testing Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 29. France Pneumonia Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 30. France Pneumonia Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 31. Italy Pneumonia Testing Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 32. Italy Pneumonia Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 33. Italy Pneumonia Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 34. Spain Pneumonia Testing Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 35. Spain Pneumonia Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 36. Spain Pneumonia Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 37. RoE Pneumonia Testing Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 38. RoE Pneumonia Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 39. RoE Pneumonia Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 40. China Pneumonia Testing Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 41. China Pneumonia Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 42. China Pneumonia Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 43. India Pneumonia Testing Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 44. India Pneumonia Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 45. India Pneumonia Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 46. Japan Pneumonia Testing Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 47. Japan Pneumonia Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 48. Japan Pneumonia Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 49. South Korea Pneumonia Testing Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 50. South Korea Pneumonia Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 51. South Korea Pneumonia Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 52. Australia Pneumonia Testing Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 53. Australia Pneumonia Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 54. Australia Pneumonia Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 55. RoAPAC Pneumonia Testing Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 56. RoAPAC Pneumonia Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 57. RoAPAC Pneumonia Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 58. Brazil Pneumonia Testing Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 59. Brazil Pneumonia Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 60. Brazil Pneumonia Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 61. Mexico Pneumonia Testing Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 62. Mexico Pneumonia Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 63. Mexico Pneumonia Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 64. RoLA Pneumonia Testing Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 65. RoLA Pneumonia Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 66. RoLA Pneumonia Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 67. Row Pneumonia Testing Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 68. Row Pneumonia Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 69. Row Pneumonia Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 70. List of secondary sources, used in the study of global Pneumonia Testing Market
  • TABLE 71. List of primary sources, used in the study of global Pneumonia Testing Market
  • TABLE 72. Years considered for the study
  • TABLE 73. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

  • FIG 1. Global Pneumonia Testing Market, research methodology
  • FIG 2. Global Pneumonia Testing Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Pneumonia Testing Market, key trends 2021
  • FIG 5. Global Pneumonia Testing Market, growth prospects 2022-2029
  • FIG 6. Global Pneumonia Testing Market, porters 5 force model
  • FIG 7. Global Pneumonia Testing Market, pest analysis
  • FIG 8. Global Pneumonia Testing Market, value chain analysis
  • FIG 9. Global Pneumonia Testing Market by segment, 2019 & 2029 (USD Billion)
  • FIG 10. Global Pneumonia Testing Market by segment, 2019 & 2029 (USD Billion)
  • FIG 11. Global Pneumonia Testing Market by segment, 2019 & 2029 (USD Billion)
  • FIG 12. Global Pneumonia Testing Market by segment, 2019 & 2029 (USD Billion)
  • FIG 13. Global Pneumonia Testing Market by segment, 2019 & 2029 (USD Billion)
  • FIG 14. Global Pneumonia Testing Market, regional snapshot 2019 & 2029
  • FIG 15. North America Pneumonia Testing Market 2019 & 2029 (USD Billion)
  • FIG 16. Europe Pneumonia Testing Market 2019 & 2029 (USD Billion)
  • FIG 17. Asia pacific Pneumonia Testing Market 2019 & 2029 (USD Billion)
  • FIG 18. Latin America Pneumonia Testing Market 2019 & 2029 (USD Billion)
  • FIG 19. Global Pneumonia Testing Market, company Market share analysis (2021)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable